EMP3 and breast cancer: The negative modulation of YTHDC1 by EMP3 and the effect of YTHDC1 overexpression on breast cancer cells together demonstrate that YTHDC1 and m6A modification at least in part mediate EMP3-induced suppression of homologous recombination repair.